Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 H & E slide staining
6.3 In-situ hybridisation
6.4 Special Stains
6.5 Digital pathology
Chapter 7 Market Segmentation by Application
7.1 Introduction
7.2 Prostrate Cancer
7.3 Lung Cancer
7.4 Colorectal Cancer
7.5 Breast Cancer
7.6 Skin Cancer
7.7 Cervical Cancer
7.8 Lymphoma
7.9 Gastric Cancer
7.10 Others
Chapter 8 Market Segmentation by End-user
8.1 Introduction
8.2 Research laboratories
8.3 Hospitals
8.4 Contract research organisation
8.5 Others
Chapter 9 Market Segmentation by Platform
9.1 Introduction
9.2 H&E Staining
9.3 Bright field scanning
9.4 High Throughput Scanning (HTS)
9.5 Special Stains
9.6 Research IHC/ISH
9.7 Specimen Workflow
9.8 Image Management
9.9 IHC/ISH Staining
Chapter 10 Market Segmentation by product
10.1 Introduction
10.2 Instrument
10.3 Consumables
Chapter 11 Market Segmentation by Geography
11.1 North America
11.1.1 Introduction
11.1.2 USA
11.1.3 Canada
11.1.4 Mexico
11.1.5 Others
11.2 Europe
11.2.1 Introduction
11.2.2 UK
11.2.3 France
11.2.4 Germany
11.2.5 Italy
11.2.6 Spain
11.2.7 Others
11.3 Asia
11.3.1 Introduction
11.3.2 Japan
11.3.3 China
11.3.4 India
11.3.5 Australia and New Zealand
11.3.6 South Korea
11.3.7 Others
11.4 South America
11.4.1 Introduction
11.4.2 Brazil
11.4.3 Argentina
11.4.4 Others
11.5 Middle-East and Africa
11.5.1 Introduction
11.5.2 South Africa
11.5.3 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 Abbott laboratories
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Benchmarking
13.1.4. Strategic Initiative
13.2 Agilent technology
13.3 Roche
13.4 Thermo Fisher scientific
13.5 Qiagen
13.6 Merck
13.7 Danaher Corporation
13.8 Biogenex Laboratories
13.9 Genomic health
13.10 Sigma-Aldrich Co LLC,
13.11 Affymetrix
13.12 Cancer genetics
13.13 Definiens
13.14 Cell signaling technologies
13.15 Abcam
Chapter 14 Market Estimates and Forecast
14.1 Market Estimates and Forecast 2018-2024(USD Million)
14.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
14.1.2 Market Estimates and Forecast by Application 2018-2024 (USD Million)
14.1.3 Market Estimates and Forecast by Product 2018-2024 (USD Million)
14.1.4 Market Estimates and Forecast by End-user 2018-2024 (USD Million)
14.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
14.1.6 Market Estimates and forecast by company Profiles 2018-2024(USD million)
Chapter 15 Market Insights
15.1 Insights of Industry Experts
15.2 Analyst Opinion (Market Understanding)
15.3 Investment Opportunities
Chapter 16 Appendix
16.1 List of Tables
16.2 List of Figures
